GRACE SKINNER: Open Payments
NPI 1457037632 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$852 in 30 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $900 · 2025 $852
Food & beverage: $852
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $284 |
| Phathom Pharmaceuticals, Inc. | 3 | $135 |
| Janssen Biotech, Inc. | 5 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $112 |
| Intercept Pharmaceuticals, Inc. | 2 | $52 |
| Ardelyx, Inc. | 2 | $47 |
| Ipsen Biopharmaceuticals, Inc | 1 | $35 |
| Madrigal Pharmaceuticals | 1 | $23 |
| Celltrion USA Inc. | 1 | $20 |
| GENZYME CORPORATION | 1 | $18 |
Products named: VOQUEZNA, SKYRIZI, TREMFYA, ENTYVIO, RINVOQ, OCALIVA, IBSRELA, CREON.
Industry payments across MA — which companies pay providers there.
